Search Results - "BAYNES, John W"

Refine Results
  1. 1

    Chelation: A Fundamental Mechanism of Action of AGE Inhibitors, AGE Breakers, and Other Inhibitors of Diabetes Complications by NAGAI, Ryoji, MURRAY, David B, METZ, Thomas O, BAYNES, John W

    Published in Diabetes (New York, N.Y.) (01-03-2012)
    “…This article outlines evidence that advanced glycation end product (AGE) inhibitors and breakers act primarily as chelators, inhibiting metal-catalyzed…”
    Get full text
    Journal Article
  2. 2

    A Perspective on the Maillard Reaction and the Analysis of Protein Glycation by Mass Spectrometry: Probing the Pathogenesis of Chronic Disease by Zhang, Qibin, Ames, Jennifer M, Smith, Richard D, Baynes, John W, Metz, Thomas O

    Published in Journal of proteome research (06-02-2009)
    “…The Maillard reaction, starting from the glycation of protein and progressing to the formation of advanced glycation end-products (AGEs), is implicated in the…”
    Get full text
    Journal Article
  3. 3

    The regulation of skeletal muscle protein turnover during the progression of cancer cachexia in the Apc(Min/+) mouse by White, James P, Baynes, John W, Welle, Stephen L, Kostek, Matthew C, Matesic, Lydia E, Sato, Shuichi, Carson, James A

    Published in PloS one (2011)
    “…Muscle wasting that occurs with cancer cachexia is caused by an imbalance in the rates of muscle protein synthesis and degradation. The Apc(Min/+) mouse is a…”
    Get full text
    Journal Article
  4. 4

    The Regulation of Skeletal Muscle Protein Turnover during the Progression of Cancer Cachexia in the ApcMin/+ Mouse by White, James P., Baynes, John W., Welle, Stephen L., Kostek, Matthew C., Matesic, Lydia E., Sato, Shuichi, Carson, James A.

    Published in PloS one (19-09-2011)
    “…Muscle wasting that occurs with cancer cachexia is caused by an imbalance in the rates of muscle protein synthesis and degradation. The ApcMin/+ mouse is a…”
    Get full text
    Journal Article
  5. 5

    Mitochondrial stress causes increased succination of proteins in adipocytes in response to glucotoxicity by Frizzell, Norma, Thomas, Sonia A, Carson, James A, Baynes, John W

    Published in Biochemical journal (15-07-2012)
    “…2SC [S-(2-succino)-cysteine] is a chemical modification formed by a Michael addition reaction of fumarate with cysteine residues in proteins. Formation of 2SC,…”
    Get more information
    Journal Article
  6. 6
  7. 7

    Muscle oxidative capacity during IL-6-dependent cancer cachexia by White, James P, Baltgalvis, Kristen A, Puppa, Melissa J, Sato, Shuichi, Baynes, John W, Carson, James A

    “…Many diseases are associated with catabolic conditions that induce skeletal muscle wasting. These various catabolic states may have similar and distinct…”
    Get more information
    Journal Article
  8. 8

    IL-6 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia in the ApcMin/+ mouse by White, James P, Puppa, Melissa J, Sato, Shuichi, Gao, Song, Price, Robert L, Baynes, John W, Kostek, Matthew C, Matesic, Lydia E, Carson, James A

    Published in Skeletal muscle (06-07-2012)
    “…Muscle protein turnover regulation during cancer cachexia is being rapidly defined, and skeletal muscle mitochondria function appears coupled to processes…”
    Get full text
    Journal Article
  9. 9

    Skin Autofluorescence Is a Strong Predictor of Cardiac Mortality in Diabetes by Meerwaldt, Robbert, Lutgers, Helen L, Links, Thera P, Graaff, Reindert, Baynes, John W, Gans, Rijk O.B, Smit, Andries J

    Published in Diabetes care (2007)
    “…OBJECTIVE:--Advanced glycation end products (AGEs) are biomarkers of metabolic stress and are thought to contribute to the increase of coronary heart disease…”
    Get full text
    Journal Article
  10. 10

    The succinated proteome by Merkley, Eric D., Metz, Thomas O., Smith, Richard D., Baynes, John W., Frizzell, Norma

    Published in Mass spectrometry reviews (01-03-2014)
    “…The post‐translational modifications (PTMs) of cysteine residues include oxidation, S‐glutathionylation, S‐nitrosylation, and succination, all of which modify…”
    Get full text
    Journal Article
  11. 11

    Citric acid inhibits development of cataracts, proteinuria and ketosis in streptozotocin (type 1) diabetic rats by Nagai, Ryoji, Nagai, Mime, Shimasaki, Satoko, Baynes, John W., Fujiwara, Yukio

    “…Although many fruits such as lemon and orange contain citric acid, little is known about beneficial effects of citric acid on health. Here we measured the…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Glycoxidation and lipoxidation in atherogenesis by Baynes, John W, Thorpe, Suzanne R

    Published in Free radical biology & medicine (15-06-2000)
    “…Atherosclerosis may be viewed as an age-related disease initiated by nonenzymatic, chemical reactions in a biological system. The peroxidation of lipids in…”
    Get full text
    Journal Article
  14. 14

    The Maillard Hypothesis on Aging: Time to Focus on DNA by BAYNES, JOHN W.

    Published in Annals of the New York Academy of Sciences (01-04-2002)
    “…Aging is the outcome of the contest between chemistry and biology in living systems. Chronic, cumulative chemical modifications compromise the structure and…”
    Get full text
    Journal Article
  15. 15

    Simple Noninvasive Measurement of Skin Autofluorescence by MEERWALDT, ROBBERT, LINKS, THERA, GRAAFF, REINDERT, THORPE, SUZANNNE R., BAYNES, JOHN W., HARTOG, JASPER, GANS, REINOLD, SMIT, ANDRIES

    Published in Annals of the New York Academy of Sciences (01-06-2005)
    “…: Accumulation of advanced glycation end products (AGEs) is thought to play a role in the pathogenesis of chronic complications of diabetes mellitus and renal…”
    Get full text
    Journal Article
  16. 16

    The anti-cancer drug, doxorubicin, causes oxidant stress-induced endothelial dysfunction by Wolf, Matthew B., Baynes, John W.

    Published in Biochimica et biophysica acta (01-02-2006)
    “…The anticancer drug doxorubicin (DOX) is toxic to target cells, but also causes endothelial dysfunction and edema, secondary to oxidative stress in the…”
    Get full text
    Journal Article
  17. 17

    The AGE Inhibitor Pyridoxamine Inhibits Development of Retinopathy in Experimental Diabetes by STITT, Alan, GARDINER, Thomas A, THORPE, Suzanne R, ANDERSON, Nathan L, CANNING, Paul, FRIZZELL, Norma, DUFFY, Noel, BOYLE, Cliona, JANUSZEWSKI, Andrzej S, CHACHICH, Mark, BAYNES, John W

    Published in Diabetes (New York, N.Y.) (01-09-2002)
    “…The AGE Inhibitor Pyridoxamine Inhibits Development of Retinopathy in Experimental Diabetes Alan Stitt 1 , Thomas A. Gardiner 1 , Nathan L. Anderson 2 , Paul…”
    Get full text
    Journal Article
  18. 18

    Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat by Degenhardt, Thorsten P., Alderson, Nathan L., Arrington, David D., Beattie, Robert J., Basgen, John M., Steffes, Michael W., Thorpe, Suzanne R., Baynes, John W.

    Published in Kidney international (01-03-2002)
    “…Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat. Nonenzymatic reactions between sugars or lipids and protein and…”
    Get full text
    Journal Article Conference Proceeding
  19. 19

    Pyridoxamine, an inhibitor of advanced glycation and lipoxidation reactions: a novel therapy for treatment of diabetic complications by Metz, Thomas O, Alderson, Nathan L, Thorpe, Suzanne R, Baynes, John W

    Published in Archives of Biochemistry and Biophysics (01-11-2003)
    “…Pyridoxamine (PM), originally described as a post-Amadori inhibitor of formation of advanced glycation end-products (AGEs), also inhibits the formation of…”
    Get full text
    Book Review Journal Article
  20. 20

    Improved Methods for the Enrichment and Analysis of Glycated Peptides by Zhang, Qibin, Schepmoes, Athena A, Brock, Jonathan W. C, Wu, Si, Moore, Ronald J, Purvine, Samuel O, Baynes, John W, Smith, Richard D, Metz, Thomas O

    Published in Analytical chemistry (Washington) (15-12-2008)
    “…Nonenzymatic glycation of tissue proteins has important implications in the development of complications of diabetes mellitus. Herein we report improved…”
    Get full text
    Journal Article